These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 27300720)
1. [Complications in the treatment of ocular surface squamous neoplasia with interferon α‑2b in rheumatoid arthritis]. Torres Suárez E; Pinheiro R; Schrage N Ophthalmologe; 2017 Feb; 114(2):155-158. PubMed ID: 27300720 [TBL] [Abstract][Full Text] [Related]
2. Surgery Versus Interferon Alpha-2b Treatment Strategies for Ocular Surface Squamous Neoplasia: A Literature-Based Decision Analysis. Siedlecki AN; Tapp S; Tosteson AN; Larson RJ; Karp CL; Lietman T; Zegans ME Cornea; 2016 May; 35(5):613-8. PubMed ID: 26890663 [TBL] [Abstract][Full Text] [Related]
3. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary? Chaugule SS; Park J; Finger PT Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124 [TBL] [Abstract][Full Text] [Related]
4. Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study. Galor A; Karp CL; Chhabra S; Barnes S; Alfonso EC Br J Ophthalmol; 2010 May; 94(5):551-4. PubMed ID: 19493859 [TBL] [Abstract][Full Text] [Related]
5. Ocular surface squamous neoplasia in a setting of fungal keratitis: a rare co-occurrence. Singh S; Mittal R; Narang P; Mittal V Int Ophthalmol; 2019 Mar; 39(3):717-720. PubMed ID: 29423784 [TBL] [Abstract][Full Text] [Related]
6. [Conjunctival squamous cell carcinoma: paradoxical response to interferon eyedrops]. Mata E; Conesa E; Castro M; Martínez L; de Pablo C; González ML Arch Soc Esp Oftalmol; 2014 Jul; 89(7):293-6. PubMed ID: 24269461 [TBL] [Abstract][Full Text] [Related]
7. Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study. Blasi MA; Maceroni M; Sammarco MG; Pagliara MM Eur J Ophthalmol; 2018 Mar; 28(2):204-209. PubMed ID: 28967069 [TBL] [Abstract][Full Text] [Related]
8. Acute Fibrinous Anterior Uveitis in a Patient Treated With Topical Interferon-α2b for Ocular Surface Squamous Neoplasia With Uveitis Susceptibility. Del-Piñal M; Klein-Burgos C; Martín-Ucero AM; Larrañaga-Cores M; de la Hoz A; López-Vázquez A; Fernández-Gutiérrez E Cornea; 2023 May; 42(5):648-650. PubMed ID: 36747320 [TBL] [Abstract][Full Text] [Related]
9. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification. Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208 [TBL] [Abstract][Full Text] [Related]
10. Retrospective Comparative Study of Topical Interferon α2b Versus Mitomycin C for Primary Ocular Surface Squamous Neoplasia. Kusumesh R; Ambastha A; Kumar S; Sinha BP; Imam N Cornea; 2017 Mar; 36(3):327-331. PubMed ID: 28079688 [TBL] [Abstract][Full Text] [Related]
11. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications. Nanji AA; Moon CS; Galor A; Sein J; Oellers P; Karp CL Ophthalmology; 2014 May; 121(5):994-1000. PubMed ID: 24411578 [TBL] [Abstract][Full Text] [Related]
12. Current Practice in the Treatment of Epithelial and Melanocytic Tumours with Interferon-α2b: A Survey of Tertiary Eye Centres in Germany. Jiang J; Böhringer D; Auw-Hädrich C; Maier PC; Barth T; Eter N; Fuest M; Geerling G; Heindl LM; Herwig-Carl M; Hintschich C; Hufendiek K; Kampik D; Lieb W; Meller D; Mueller A; Pfeiffer N; Rehak M; Schargus M; Seitz B; Spitzer M; Stahl A; Süsskind D; van Oterendorp C; Wagner FM; Westekemper H; Ziemssen F; Reinhard T Klin Monbl Augenheilkd; 2023 Jul; 240(7):891-896. PubMed ID: 36746398 [TBL] [Abstract][Full Text] [Related]
13. Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia. Ashkenazy N; Karp CL; Wang G; Acosta CM; Galor A Cornea; 2017 Apr; 36(4):506-510. PubMed ID: 28129301 [TBL] [Abstract][Full Text] [Related]
15. Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia. Holcombe DJ; Lee GA Am J Ophthalmol; 2006 Oct; 142(4):568-71. PubMed ID: 17011846 [TBL] [Abstract][Full Text] [Related]
16. Recombinant interferon alpha 2b for ocular surface squamous neoplasia: An efficient and cost-effective treatment modality in Asian Indian patients. Kaliki S; Singh S; Iram S; Tripuraneni D Indian J Ophthalmol; 2016 Oct; 64(10):702-709. PubMed ID: 27905329 [TBL] [Abstract][Full Text] [Related]